Baolingbao Biology Co.,Ltd. (SHE:002286)

China · Delayed Price · Currency is CNY

9.09

+0.11 (1.22%)

Jun 23, 2026, 3:04 PM CST

-14.25% (1Y)

Market Cap	3.42B -15.9%
Revenue (ttm)	2.81B +11.0%
Net Income	154.40M +11.6%
EPS	0.41 +8.6%
Shares Out	380.57M
PE Ratio	21.76
Forward PE	16.94
Dividend	0.12 (1.35%)
Ex-Dividend Date	Jul 3, 2025

Volume	6,882,400
Open	9.01
Previous Close	8.98
Day's Range	8.92 - 9.24
52-Week Range	8.52 - 13.40
Beta	0.48
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Baolingbao Biology

Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, incl... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1997

Employees 1,505

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002286

Full Company Profile

Financial Performance

In 2025, Baolingbao Biology's revenue was 2.75 billion, an increase of 14.54% compared to the previous year's 2.40 billion. Earnings were 150.63 million, an increase of 35.50%.

Financial Statements